
Investigators suggest the findings mean anticoagulants or antiplatelets could potentially treat migraine patients with aura.

Investigators suggest the findings mean anticoagulants or antiplatelets could potentially treat migraine patients with aura.

Trazodone is a depression drug, but it blocks the integrated stress response, so it may be a good candidate for ALS.

Patients administered either anti-VEGF therapy for nAMD tested similar for improved visual acuity over an observed 12-month treatment period.

The patient started treatment with resperidone at age 7 but wasn't diagnosed with tardive dyskinesia until age 17.

The oncolytic adenovirus was safe in terms of toxicity in mice models.

The medulloblastoma subset has a poor prognosis, so investigators have been looking for new treatment options.

There are only 4 case reports of this cancer in muscular dystrophy patients.

For 2 years after C difficile infection, patients under 65 years were at greater risk for gastrointestinal diagnoses compared to uninfected patients.

Investigators hope their findings will alleviate clinicians’ concerns about choosing between fidaxomicin and oral vancomycin for treatment.

Some of the new subtypes are similar to previously identified ones but show similar prognoses to established subtypes.

The surgery restored arm movement and function in children affected by acute flaccid myelitis.

Older age was associated with a lower likelihood of entering the ICU, but increased risk of death for hospitalized patients with influenza.

River blindness and elephantiasis are 2 of the leading causes of global disability.

Improvements in muscle and cardiac function were observed for 18 months in tested mice.

Success with metronidazole was more likely in patients 65 years and under but was about the same as with vancomycin in those patients.

More specificity with this group of disorders will help treat them the appropriate way.

Only patients with very serious, life-threatening conditions with a risk/benefit ratio is acceptable for use of the therapy at this time.

The new C difficile guidelines highlight improvements in diagnosing the condition and treating with newer options like fidaxomicin, vancomycin, and fecal microbiota transplantation.

At 10%, recurrence was lower in this analysis compared to other pediatric studies.

The study focused on patients with bipolar or depressive disorder.

A retrospective study showed which patients with substance use disorder may have less successful antiepileptic drug treatment.

Despite the cost, ultraviolet disinfection helped reduce infection rates in a recent study.

Over 2 years, lacosamide was effective and generally well tolerated among adults with newly diagnosed epilepsy, compared to carbamazepine.

Patient and caregiver assessments should be considered alongside clinician assessments during tardive dyskinesia screening procedures, as they may differ.

It remains unclear whether clozapine treats or suppresses the symptoms of tardive dyskinesia.

While the absolute risk of therapy-related blood cancers is low, the treatment is often intensive and linked to substantial morbidity.

In a 10-patient study, sutimlimab halted the destruction of red blood cells in patients with cold agglutinin disease.

The polio-like AFM is an emerging health concern, with outbreaks documented since 2012.

Investigators found significant differences among patient income quartile zip codes, as well as different age cohorts.

The classic Fabry disease phenotype in men is almost exclusively marked by anti-agalsidase antibody development, despite having no clear clinical impact.